These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38716552)

  • 21. An Overview of Recent Advances in the Neuroprotective Potentials of Fisetin against Diverse Insults in Neurological Diseases and the Underlying Signaling Pathways.
    Tang X; Deng P; Jiang Y; Zhang L; He Y; Yang H
    Biomedicines; 2023 Oct; 11(11):. PubMed ID: 38001882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fisetin: A bioactive phytochemical with potential for cancer prevention and pharmacotherapy.
    Kashyap D; Sharma A; Sak K; Tuli HS; Buttar HS; Bishayee A
    Life Sci; 2018 Feb; 194():75-87. PubMed ID: 29225112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genotoxic and Cytotoxic Activity of Fisetin on Glioblastoma Cells.
    Beltzig L; Christmann M; Dobreanu M; Kaina B
    Anticancer Res; 2024 Mar; 44(3):901-910. PubMed ID: 38423634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nobiletin as a Molecule for Formulation Development: An Overview of Advanced Formulation and Nanotechnology-Based Strategies of Nobiletin.
    Kesharwani SS; Mallya P; Kumar VA; Jain V; Sharma S; Dey S
    AAPS PharmSciTech; 2020 Aug; 21(6):226. PubMed ID: 32761293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fisetin averts oxidative stress in pancreatic tissues of streptozotocin-induced diabetic rats.
    Prasath GS; Sundaram CS; Subramanian SP
    Endocrine; 2013 Oct; 44(2):359-68. PubMed ID: 23277230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fisetin Induces Apoptosis Through p53-Mediated Up-Regulation of DR5 Expression in Human Renal Carcinoma Caki Cells.
    Min KJ; Nam JO; Kwon TK
    Molecules; 2017 Aug; 22(8):. PubMed ID: 28767099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fisetin Suppresses Macrophage-Mediated Inflammatory Responses by Blockade of Src and Syk.
    Kim JH; Kim MY; Kim JH; Cho JY
    Biomol Ther (Seoul); 2015 Sep; 23(5):414-20. PubMed ID: 26336580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Fisetin, a Plant-Derived Flavonoid, on Response to Oxidative Stress, Aging, and Age-Related Diseases in
    Park S; Kim BK; Park SK
    Pharmaceuticals (Basel); 2022 Dec; 15(12):. PubMed ID: 36558979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fisetin inhibits pristine-induced systemic lupus erythematosus in a murine model through CXCLs regulation.
    Xu SP; Li YS
    Int J Mol Med; 2018 Dec; 42(6):3220-3230. PubMed ID: 30272314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of Akt/mTOR signaling by the dietary flavonoid fisetin.
    Syed DN; Adhami VM; Khan MI; Mukhtar H
    Anticancer Agents Med Chem; 2013 Sep; 13(7):995-1001. PubMed ID: 23293889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
    Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ISA 247: trans-ISA 247, trans-R 1524, ISA(TX)247, ISAtx 247, ISATx247, LX 211, LX211, R 1524, R-1524.
    Drugs R D; 2007; 8(2):103-12. PubMed ID: 17324008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved neuroprotective activity of Fisetin through SNEDDS in ameliorating the behavioral alterations produced in rotenone-induced Parkinson's model.
    Kumar R; Kumar R; Khurana N; Singh SK; Khurana S; Verma S; Sharma N; Vyas M; Dua K; Khursheed R; Awasthi A; Vishwas S
    Environ Sci Pollut Res Int; 2022 Jul; 29(33):50488-50499. PubMed ID: 35230633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fisetin, a 3,7,3',4'-Tetrahydroxyflavone Inhibits the PI3K/Akt/mTOR and MAPK Pathways and Ameliorates Psoriasis Pathology in 2D and 3D Organotypic Human Inflammatory Skin Models.
    Chamcheu JC; Esnault S; Adhami VM; Noll AL; Banang-Mbeumi S; Roy T; Singh SS; Huang S; Kousoulas KG; Mukhtar H
    Cells; 2019 Sep; 8(9):. PubMed ID: 31540162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Withaferin A: A Dietary Supplement with Promising Potential as an Anti-Tumor Therapeutic for Cancer Treatment - Pharmacology and Mechanisms.
    Xing Z; Su A; Mi L; Zhang Y; He T; Qiu Y; Wei T; Li Z; Zhu J; Wu W
    Drug Des Devel Ther; 2023; 17():2909-2929. PubMed ID: 37753228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative study of the aneugenic and polyploidy-inducing effects of fisetin and two model Aurora kinase inhibitors.
    Gollapudi P; Hasegawa LS; Eastmond DA
    Mutat Res Genet Toxicol Environ Mutagen; 2014 Jun; 767():37-43. PubMed ID: 24680981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Potential Role of Fisetin, a Flavonoid in Cancer Prevention and Treatment.
    Rahmani AH; Almatroudi A; Allemailem KS; Khan AA; Almatroodi SA
    Molecules; 2022 Dec; 27(24):. PubMed ID: 36558146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of new fisetin analogs as kinase inhibitors: Data on synthesis and anti-skin cancer activities evaluation.
    Roy T; Boateng ST; Banang-Mbeumi S; Singh PK; Basnet P; Chamcheu RN; Ladu F; Chauvin I; Spiegelman VS; Hill RA; Kousoulas KG; Nagalo BM; Walker AL; Fotie J; Murru S; Sechi M; Chamcheu JC
    Data Brief; 2021 Apr; 35():106858. PubMed ID: 33665254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fisetin treatment alleviates kidney injury in mice with diabetes-exacerbated atherosclerosis through inhibiting CD36/fibrosis pathway.
    Zou TF; Liu ZG; Cao PC; Zheng SH; Guo WT; Wang TX; Chen YL; Duan YJ; Li QS; Liao CZ; Xie ZL; Han JH; Yang XX
    Acta Pharmacol Sin; 2023 Oct; 44(10):2065-2074. PubMed ID: 37225845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A review on the chemotherapeutic potential of fisetin: In vitro evidences.
    Sundarraj K; Raghunath A; Perumal E
    Biomed Pharmacother; 2018 Jan; 97():928-940. PubMed ID: 29136771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.